Search Results for "Drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug. Results 2161 to 2170 of 2581 total matches.
In Brief: Asparaginase Erwinia chrysanthemi (Erwinaze) for ALL
The Medical Letter on Drugs and Therapeutics • Apr 16, 2012 (Issue 1388)
The Medical Letter®
On Drugs and Therapeutics
Volume 54 (Issue 1388)
April 16, 2012 ...
The FDA has approved asparaginase Erwinia chrysanthemi (Erwinaze – EUSA), an asparagine-specific enzyme derived from the gram-negative bacillus Erwinia chrysanthemi, for use in combination with other chemotherapeutic agents for treatment of acute lymphoblastic leukemia (ALL) in patients who have had allergic reactions to Escherichia coli-derived asparaginase (Elspar or pegaspargase [Oncaspar]).ALL is the most common malignancy of childhood. Multidrug chemotherapy can cure about 80% of children with ALL.1 Initial treatment ("induction") usually includes vincristine, a glucocorticoid, and an...
In Brief: Epinephrine Auto-Injectors for Anaphylaxis (online only)
The Medical Letter on Drugs and Therapeutics • Sep 12, 2016 (Issue 1503)
of epinephrine
doses, including failure to deliver the drug.1
Adrenaclick and its generic equivalent ...
News about recent price increases for EpiPen and EpiPen Jr (Mylan) may have patients asking about other options for emergency treatment of anaphylaxis. Adrenaclick and its generic equivalent (epinephrine injection auto-injector) are the only other epinephrine auto-injectors currently available in the US. According to Impax (the manufacturer of both the brand and generic products), Adrenaclick is no longer being manufactured; the generic product will continue to be marketed after supplies of Adrenaclick are depleted. Auvi-Q (Sanofi), an epinephrine auto-injector that was approved by the FDA in...
Vitamin Supplements
The Medical Letter on Drugs and Therapeutics • Jul 18, 2005 (Issue 1213)
Letter
®
On Drugs and Therapeutics
IN THIS ISSUE
Vitamin Supplements
Volume 47 (Issue 1213)
July ...
Many patients ask their physicians whether they should take vitamins. Since the last Medical Letter article on this subject, more data have become available on the benefits and risks of taking vitamin supplements.
Alpha-Galactosidase to Prevent Gas
The Medical Letter on Drugs and Therapeutics • Apr 02, 1993 (Issue 893)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
The enzyme alpha-galactosidase (Beano - AkPharma), derived from a mold and classified as a food, is sold without presecription in pharmacies and food stores. The manufacturer recommends taking the anzyme to decrease intestinal gas producted by eating the high-fiber diets now widely recommended in the USA.
OncoScint for Detetion of Disseminated Colorectal and Ovarian Cancer
The Medical Letter on Drugs and Therapeutics • Jun 11, 1993 (Issue 898)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Indium 111 In-satumomab pendetide (CYT-103, OncoScint CR/OV Kit - Cytogen), a new intravenous imaging agent, has been approved by the US Food and Drug Administration for detection of extrahepatic spread of colorectal and ovarian tumors.
Radioactive Strontium-89 for Painful Bone Metastases
The Medical Letter on Drugs and Therapeutics • Oct 29, 1993 (Issue 908)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Strontium-89 chloride was recently approved for marketing by the US Food and Drug Administration. It is offered for relief of pain caused by metastatic bone lesions
Dexrazoxane for Cardiac Protection Against Doxorubicin
The Medical Letter on Drugs and Therapeutics • Nov 24, 1995 (Issue 962)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Dexrazoxane (Zinecard - Pharmacia) was recently approved by the US Food and Drug Administration (FDA) for protection against cardiac toxicity from (Adriamycin, and others) in women with metastatic breast cancer.
Bone Densitometry
The Medical Letter on Drugs and Therapeutics • Nov 22, 1996 (Issue 988)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Use of alendronate (Fosamax), estrogen and other drugs for prevention and treatment of osteoporosis (Medical Letter, 38:1, 1996) has been accompanied by widespread availability of bone density screening tests, not only in doctors offices and hospitals, but even in retail stores. Bone densitometry provides a quantitative measurement of bone mineralization that can be used to predict the risk of osteoporotic fractures.
Dolasetron for Prevention of Nausea and Vomiting Due to Cancer Chemotherapy
The Medical Letter on Drugs and Therapeutics • May 08, 1998 (Issue 1026)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Dolasetron (Anzemet - Hoechst Marion Roussel), a selective serotonin (5-HT3) receptor antagonist similar to ondansetron (Zofran) and granisetron (Kytril - Medical Letter, 36:61, 1994) is now available for both oral and intravenous use in prevention of nausea and vomiting due to cancer chemotherapy. A 5-HT3 antagonist plus dexamethasone (Decadron, and others) is the most effective regimen for prevention of acute vomiting caused by cancer chemotherapy. Dolasetron has also been approved by the FDA for prevention and treatment of postoperative nausea and...
Ginkgo Biloba for Dementia
The Medical Letter on Drugs and Therapeutics • Jun 19, 1998 (Issue 1029)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Extracts made from leaves of the ginkgo tree (Ginkgo biloba) are available in the uSA as deitary supplements, in France and Germany as licensed drugs and worldwide as herbal remedies for treatment of dementia and many other indications.